The internal structure of the WRISc

Abstract: Personality-based integrity tests are used in selection procedures to reduce the chance of hiring employees who are likely to engage in counterproductive work behaviour. The present study reports the internal psychometric properties of a new personality-based measure developed for this purpose. Data collected from 1353 working adults were used to investigate internal consistency reliability, and to examine construct validity with confirmatory factor analysis and Rasch analysis. Results showed that the reliability estimates for all the scales of the assessment were satisfactory. For the confirmatory factor analysis, inspection of the incremental (CFI and TLI) and absolute (RMSEA) goodness-of fit values found strong support for the construct validity of all the scales. Infit statistics from Rasch analysis provided further support for construct validity, with items from all the scales fitting the Rasch model. Combined the confirmatory and Rasch analysis demonstrated that unidimensional, coherent and meaningful latent constructs are being measured on the WRISc. Overall, results found excellent support for the internal psychometric properties of the instrument in a culturally diverse context

The factor structure of the Edinburgh Postnatal Depression scale in a South African peri-urban settlement

The factor structure of the Edinburgh Postnatal Depression scale (EPDS) and similar instruments have received little attention in the literature. The researchers set out to investigate the construct validity and reliability of the EPDS amongst impoverished South African women. The EPDS was translated into isiXhosa (using Brislin's back translation method) and administered by trained interviewers to 147 women in Khayelitsha, South Africa. Responses were subjected to maximum likelihood confirmatory factor analysis. A single factor structure was found, consistent with the theory on which the EPDS was based. Internal consistency was satisfactory (a =0.89)

Identification of gene clusters differentially expressed during the cellular injury responses (CIR) to cisplatin

The goal of this study was to identify changes in mRNA levels in tumour cells after a toxic exposure to cisplatin (IC99dose). Using suppression-subtractive hybridization (SSH) 2 cDNA libraries were created, an UP library (202 cDNA fragments) and a DOWN library (153 cDNA fragments). Using reversed Northern hybridization 16 and 30 fragments were truly differentially expressed in the UP and DOWN libraries, respectively. Most prominent in the UP library were the mitochondrial and injury response clusters and in the DOWN library the cytoskeletal, protein synthesis and signalling clusters. These distinct clusters potentially represent an expression profile of the cisplatin-induced cellular injury response. © 2001 Cancer Research Campaign  http://www.bjcancer.co

Chytrid epidemics may increase genetic diversity of a diatom spring-bloom

Contrary to expectation, populations of clonal organisms are often genetically highly diverse. In phytoplankton, this diversity is maintained throughout periods of high population growth (that is, blooms), even though competitive exclusion among genotypes should hypothetically lead to the dominance of a few superior genotypes. Genotype-specific parasitism may be one mechanism that helps maintain such high-genotypic diversity of clonal organisms. Here, we present a comparison of population genetic similarity by estimating the beta-dispersion among genotypes of early and peak bloom populations of the diatom Asterionella formosa for three spring-blooms under high or low parasite pressure. The Asterionella population showed greater beta-dispersion at peak bloom than early bloom in the 2 years with high parasite pressure, whereas the within group dispersion did not change under low parasite pressure. Our findings support that high prevalence parasitism can promote genetic diversification of natural populations of clonal hosts

Reproducibility and Data Storage for Active Learning-Aided Systematic Reviews

In the screening phase of a systematic review, screening prioritization via active learning effectively reduces the workload. However, the PRISMA guidelines are not sufficient for reporting the screening phase in a reproducible manner. Text screening with active learning is an iterative process, but the labeling decisions and the training of the active learning model can happen independently of each other in time. Therefore, it is not trivial to store the data from both events so that one can still know which iteration of the model was used for each labeling decision. Moreover, many iterations of the active learning model will be trained throughout the screening process, producing an enormous amount of data (think of many gigabytes or even terabytes of data), and machine learning models are continually becoming larger. This article clarifies the steps in an active learning-aided screening process and what data is produced at every step. We consider what reproducibility means in this context and we show that there is tension between the desire to be reproducible and the amount of data that is stored. Finally, we present the RDAL Checklist (Reproducibility and Data storage for Active Learning-Aided Systematic Reviews Checklist), which helps users and creators of active learning software make their screening process reproducible

Evidence for local inflammation in complex regional pain syndrome type 1.

BACKGROUND: The pathophysiology of complex regional pain syndrome type 1 (CRPS 1) is still a matter of debate. Peripheral afferent, efferent and central mechanisms are supposed. Based on clinical signs and symptoms (e.g. oedema, local temperature changes and chronic pain) local inflammation is suspected. AIM: To determine the involvement of neuropetides, cytokines and eicosanoids as locally formed mediators of inflammation. METHODS: In this study, nine patients with proven CRPS 1 were included. Disease activity and impairment was determined by means of a Visual Analogue Scale, the McGill Pain Questionnaire, the difference in volume and temperature between involved and uninvolved extremities, and the reduction in active range of motion of the involved extremity. Venous blood was sampled from and suction blisters made on the involved and uninvolved extremities for measurement of cytokines interleukin (IL)-6, II-1beta and tumour necrosis factor-alpha (TNF-alpha), the neuropetides NPY and CRGP, and prostaglandin E2RESULTS: The patients included in this study did have a moderate to serious disease activity and impairment. In plasma, no changes of mediators of inflammation were observed. In blister fluid, however, significantly higher levels of IL-6 and TNF-alpha in the involved extremity were observed in comparison with the uninvolved extremity. CONCLUSIONS: This is the first time that involvement of mediators of inflammation in CRPS 1 has been so clearly and directly demonstrated. This observation opens new approaches for the succesful use and development of immunosuppressives in CRPS 1

Integration of a smoking cessation program in the treatment protocol for patients with head and neck and lung cancer

Smoking is the main causative factor for development of head and neck and lung cancer. In addition, other malignancies such as bladder, stomach, colorectal, kidney and pancreatic cancer have a causative relation with smoking. Continued smoking after having been diagnosed with cancer has many negative consequences: effectiveness of radiotherapy is diminished, survival time is shortened and risks of recurrence, second primary malignancies and treatment complications are increased. In view of the significant health consequences of continued smoking, therefore, additional support for patients to stop smoking seems a logical extension of the present treatment protocols for smoking-related cancers. For prospectively examining the effect of nursing-delivered smoking cessation programme for patients with head and neck or lung cancer, 145 patients with head and neck or lung cancer enrolled into this programme over a 2-year period. Information on smoking behaviour, using a structured, programme specific questionnaire, was collected at baseline, and after 6 and 12 months. At 6 months, 58 patients (40%) had stopped smoking and at 12 months, 48 patients (33%) still had refrained from smoking. There were no differences in smoking cessation results between patients with head and neck and lung cancer. The only significant factor predicting success was whether the patient had made earlier attempts to quit smoking. A nurse-managed smoking cessation programme for patients with head and neck or lung cancer shows favourable long-term success rates. It seems logical, therefore, to integrate such a programme in treatment protocols for smoking-related cancers